26
Views
21
CrossRef citations to date
0
Altmetric
Original Article

White Cell Count During Maintenance Chemotherapy for Standard-Risk Childhood Acute Lymphoblastic Leukemia: Relation to Relapse Rate

, &
Pages 259-267 | Received 11 Jan 1988, Accepted 08 Apr 1988, Published online: 09 Jul 2009

References

  • Frei E, Canellos GP. Dose: A critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594
  • Van Prooijen R, van der Kleijn E, Haanen C. Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharm Ther 1977; 21: 744–750
  • Craft AW, Rankin A, Aherne W. Methotrexate absorption in children with acute lymphoblastic leukemia. Cancer Treat Rep 1981; 65(suppl 1)77–91
  • Evans WE, Crom WR, Stewart CF, et al. Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukemia. Lancet 1984; i: 359–362
  • Simone JV. The treatment of acute lymphoblastic leukemia. Br J Haematol 1980; 45: 1
  • Moe PJ. Recent advances in the management of acute lymphocytic leukemia. Eur Paediafr Haematol Oncol 1984; 1: 19–28
  • Pinkel D, Hernandez K, Borella L, et al. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer 1971; 37: 247–256
  • Kearney PJ, Light PA, Preece A, Mott MG. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 1979; 12: 117–120
  • Pinkerton CR, Welshman SG, Kelley JG, Shanks RG, Bridges JM. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukemia. Cancer Chemother Pharmacol 1982; 10: 36–39
  • Harvey VJ, Slevin ML, Woolard RC, et al. The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing of chemotherapy. Chemother Pharmacol 1984; 13: 91–94
  • Zimm S, Collins JM, Riccardi R, et al. Variable bioavailability of oral mercaptopurine. N Engl J Med 1983; 308: 1005–1009
  • Lafolie P, Hayder S, Bjørk O, Ahstrøm L, Liliemark J, Peterson C. Large interindividual variation in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukemia and non-Hodgkin's lymphoma. Acta Paediatr Scand 1986; 75: 797–803
  • Ewans WE, Hutson PR, Stewart CF, et al. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion. Cancer Pharmacol Ther 1983; 33: 301–307
  • Riccardi R, Vigersky RA, Barnes S, Bleyer WA, Poplack DG. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res 1982; 42: 1617–1619
  • Bowman WP, Aur R JA, Hustu HO, Rivera G. Isolated testicular relapse in acute lymphoblastic leukemia of childhood: Categories and influence on survival. J Clin Oncol 1984; 2: 924–929
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–481
  • Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170
  • Cox, Dr. Regression models and life-tables. J R Soc Sci B 1972; 34: 187–202
  • BMDP Statistical Software, WJ Dixon. University of California Press, Los Angeles 1981
  • Gustavsson G, Garwicz S, Hertz H, et al. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five nordic countries. Incidence, patients' characteristics and treatment results. Acta Paediatr Scand 1987; 76: 781–788
  • Rivard GE, Infante-Rivard C, Hoyoux C, Champagne J. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: Better in the eventing. Lancet 1985; ii: 1264–1266
  • Schrosder H, Clausen N, Østergaard E, Pressler T. Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment. Cancer Chemother Pharmacol 1986; 16: 190–193
  • Schmiegelow K, Bruunshuus I. Red blood cell 6-thioguanine-nucleotides in childhood acute lymphoblastic leukemia, (In prep.)
  • Baumer JH, Mott MG. Sex and prognosis in childhood acute lymphoblastic leukaemia. Lancet 1978; ii: 128–129
  • Lilleyman JS, Lennard L, Rees CA, Morgan G, Maddocks JL. Childhood lymphoblastic leukemia: Sex difference in 6-mercaptopurine utilization. Br J Cancer 1984; 49: 703–707
  • Balis FM, Savitch JL, Bleyer WA. Pharmacokinetics of oral methotrexate in children. Cancer Res 1983; 43: 2342–2345
  • Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Eagl J Med 1983; 309: 1094–1104
  • Zimm S, Reaman G, Murphy RF, Poplack DG. Biochemical parameters of mercaptopurine in patients with acute lymphoblastic leukemia. Cancer Res 1986; 46: 1495–1498

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.